How virus persistence can initiate the tumorigenesis process

doi:10.5501/wjv.v2.i2.102

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7393)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

435

HTML

3653

Figures (1-2)

754

Tables (1-3)

262

Sum=5104

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1182

Download

1107

Sum=2289

May 12, 2013 (publication date) through Dec 1, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Virol. May 12, 2013; 2(2): 102-109
Published online May 12, 2013. doi: 10.5501/wjv.v2.i2.102

Table 3 Virus products controlling cellular epigenetic modifications

Virus	EBV	HHV-8	HPV	HBV	HCV	HTLV-1
	EBNA-3A, EBNA-3C[78]	LANA-1[81]	E6[83]	HBx[85,86]	Core[87]	Tax[88]
	LMP-1[79]	microRNA[82]	E7[84]
	LMP-2[80]

EBV: Epstein-Barr virus; HHV-8: Human herpesvirus 8, also named Kaposi sarcoma virus; HPV: Human papillomavirus; HBV: Hepatatis B virus; HCV: Hepatitis C virus; HTLV-1: Human T-cell leukemia virus 1.

Citation: Avanzi S, Alvisi G, Ripalti A. How virus persistence can initiate the tumorigenesis process. World J Virol 2013; 2(2): 102-109
URL: https://www.wjgnet.com/2220-3249/full/v2/i2/102.htm
DOI: https://dx.doi.org/10.5501/wjv.v2.i2.102